vs
Side-by-side financial comparison of Agape ATP Corp (ATPC) and SenesTech, Inc. (SNES). Click either name above to swap in a different company.
SenesTech, Inc. is the larger business by last-quarter revenue ($421.0K vs $399.1K, roughly 1.1× Agape ATP Corp). Agape ATP Corp runs the higher net margin — -94.4% vs -428.5%, a 334.1% gap on every dollar of revenue. On growth, Agape ATP Corp posted the faster year-over-year revenue change (10.9% vs -16.0%). Over the past eight quarters, Agape ATP Corp's revenue compounded faster (11.9% CAGR vs 0.7%).
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
ATPC vs SNES — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $399.1K | $421.0K |
| Net Profit | $-376.9K | $-1.8M |
| Gross Margin | 58.6% | 55.3% |
| Operating Margin | -325.2% | -446.8% |
| Net Margin | -94.4% | -428.5% |
| Revenue YoY | 10.9% | -16.0% |
| Net Profit YoY | 53.4% | -43.7% |
| EPS (diluted) | $-2.76 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $399.1K | $421.0K | ||
| Q3 25 | $370.6K | $690.0K | ||
| Q2 25 | $465.5K | $625.0K | ||
| Q1 25 | $289.0K | $485.0K | ||
| Q4 24 | $359.8K | $501.0K | ||
| Q3 24 | $331.3K | $482.0K | ||
| Q2 24 | $313.0K | $459.0K | ||
| Q1 24 | $318.6K | $415.0K |
| Q4 25 | $-376.9K | $-1.8M | ||
| Q3 25 | $-586.8K | $-1.3M | ||
| Q2 25 | $-617.1K | $-1.6M | ||
| Q1 25 | $-698.9K | $-1.7M | ||
| Q4 24 | $-808.4K | $-1.3M | ||
| Q3 24 | $-509.6K | $-1.5M | ||
| Q2 24 | $-442.7K | $-1.6M | ||
| Q1 24 | $-709.7K | $-1.8M |
| Q4 25 | 58.6% | 55.3% | ||
| Q3 25 | 64.5% | 62.8% | ||
| Q2 25 | 44.9% | 65.4% | ||
| Q1 25 | 54.1% | 64.5% | ||
| Q4 24 | 49.5% | 60.9% | ||
| Q3 24 | 55.6% | 65.4% | ||
| Q2 24 | 61.8% | 54.2% | ||
| Q1 24 | 63.8% | 32.5% |
| Q4 25 | -325.2% | -446.8% | ||
| Q3 25 | -162.3% | -195.2% | ||
| Q2 25 | -136.8% | -258.2% | ||
| Q1 25 | -249.2% | -342.9% | ||
| Q4 24 | -235.7% | -250.9% | ||
| Q3 24 | -165.4% | -321.0% | ||
| Q2 24 | -144.9% | -349.0% | ||
| Q1 24 | -227.1% | -444.1% |
| Q4 25 | -94.4% | -428.5% | ||
| Q3 25 | -158.3% | -188.1% | ||
| Q2 25 | -132.6% | -258.6% | ||
| Q1 25 | -241.8% | -343.3% | ||
| Q4 24 | -224.7% | -250.5% | ||
| Q3 24 | -153.8% | -313.9% | ||
| Q2 24 | -141.4% | -345.1% | ||
| Q1 24 | -222.7% | -441.4% |
| Q4 25 | $-2.76 | $0.48 | ||
| Q3 25 | $-0.01 | $-0.28 | ||
| Q2 25 | $-0.01 | $-0.87 | ||
| Q1 25 | $-0.07 | $-1.28 | ||
| Q4 24 | $-31.31 | $-0.15 | ||
| Q3 24 | $-0.13 | $-2.07 | ||
| Q2 24 | $-0.12 | $-3.08 | ||
| Q1 24 | $-0.18 | $-3.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $140.1K | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $22.5M | $9.6M |
| Total Assets | $24.6M | $12.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $140.1K | $8.6M | ||
| Q3 25 | $133.7K | $10.2M | ||
| Q2 25 | $216.0K | $6.1M | ||
| Q1 25 | $578.8K | $1.7M | ||
| Q4 24 | $2.0M | $1.3M | ||
| Q3 24 | $2.7M | $2.5M | ||
| Q2 24 | $3.2M | $2.0M | ||
| Q1 24 | $3.6M | $3.6M |
| Q4 25 | $22.5M | $9.6M | ||
| Q3 25 | $22.8M | $11.3M | ||
| Q2 25 | $23.4M | $7.0M | ||
| Q1 25 | $24.0M | $2.9M | ||
| Q4 24 | $1.9M | $2.5M | ||
| Q3 24 | $2.7M | $3.7M | ||
| Q2 24 | $3.2M | $3.1M | ||
| Q1 24 | $3.7M | $4.6M |
| Q4 25 | $24.6M | $12.8M | ||
| Q3 25 | $24.4M | $14.6M | ||
| Q2 25 | $24.7M | $10.4M | ||
| Q1 25 | $25.2M | $3.6M | ||
| Q4 24 | $3.2M | $3.3M | ||
| Q3 24 | $4.0M | $4.4M | ||
| Q2 24 | $4.3M | $4.0M | ||
| Q1 24 | $4.8M | $5.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-208.3K | $-1.7M |
| Free Cash FlowOCF − Capex | — | $-1.7M |
| FCF MarginFCF / Revenue | — | -398.3% |
| Capex IntensityCapex / Revenue | — | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-208.3K | $-1.7M | ||
| Q3 25 | $-256.7K | $-1.4M | ||
| Q2 25 | $-494.5K | $-1.1M | ||
| Q1 25 | $-1.5M | $-1.6M | ||
| Q4 24 | $-645.3K | $-1.2M | ||
| Q3 24 | $-424.9K | $-1.4M | ||
| Q2 24 | $-412.5K | $-1.6M | ||
| Q1 24 | $-1.2M | $-1.8M |
| Q4 25 | — | $-1.7M | ||
| Q3 25 | — | $-1.4M | ||
| Q2 25 | — | $-1.2M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-1.8M |
| Q4 25 | — | -398.3% | ||
| Q3 25 | — | -205.9% | ||
| Q2 25 | — | -191.5% | ||
| Q1 25 | — | -328.5% | ||
| Q4 24 | — | -246.1% | ||
| Q3 24 | — | -296.1% | ||
| Q2 24 | — | -354.2% | ||
| Q1 24 | — | -441.2% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 6.1% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 5.8% | ||
| Q2 24 | — | 8.5% | ||
| Q1 24 | — | 0.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
